Vaccine innovations for emerging infectious diseases—a symposium report

Jennifer Cable; Padmini Srikantiah; James E. Crowe; Bali Pulendran; Adrian Hill; Ann Ginsberg; Wayne Koff; Anuja Mathew; Tony Ng; Kathrin Jansen; Gregory Glenn; Sallie Permar; Ian Wilson; David B. Weiner; Drew Weissman; Rino Rappuoli

doi:10.1111/nyas.14235

Vaccine innovations for emerging infectious diseases—a symposium report

Jennifer Cable, Padmini Srikantiah, James E. Crowe, Bali Pulendran, Adrian Hill, Ann Ginsberg, Wayne Koff, Anuja Mathew, Tony Ng, Kathrin Jansen, Gregory Glenn, Sallie Permar, Ian Wilson, David B. Weiner, Drew Weissman, Rino Rappuoli

Microbiology & Immunology

Research output: Contribution to journal › Comment/debate › peer-review

14 Scopus citations

Abstract

Vaccines have been incredibly successful at stemming the morbidity and mortality of infectious diseases worldwide. However, there are still no effective vaccines for many serious and potentially preventable infectious diseases. Advances in vaccine technology, including new delivery methods and adjuvants, as well as progress in systems biology and an increased understanding of the human immune system, hold the potential to address these issues. In addition, maternal immunization has opened an avenue to address infectious diseases in neonates and very young infants. This report summarizes the presentations from a 1-day symposium at the New York Academy of Sciences entitled “Innovative Vaccines against Resistant Infectious Diseases and Emerging Threats,” held on May 20, 2019.

Original language	English (US)
Pages (from-to)	14-26
Number of pages	13
Journal	Annals of the New York Academy of Sciences
Volume	1462
Issue number	1
DOIs	https://doi.org/10.1111/nyas.14235
State	Published - 2020

Keywords

CMV
DNA vaccine
Ebola
HIV
MERS
RNA vaccine
RSV
Zika
antimicrobial resistance
infectious disease
influenza
malaria
maternal immunization
monoclonal antibodies
systems vaccinology
tuberculosis
vaccine
vaccinology

ASJC Scopus subject areas

General Neuroscience
General Biochemistry, Genetics and Molecular Biology
History and Philosophy of Science

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/nyas.14235

Cite this

Cable, J., Srikantiah, P., Crowe, J. E., Pulendran, B., Hill, A., Ginsberg, A., Koff, W., Mathew, A., Ng, T., Jansen, K., Glenn, G., Permar, S., Wilson, I., Weiner, D. B., Weissman, D., & Rappuoli, R. (2020). Vaccine innovations for emerging infectious diseases—a symposium report. Annals of the New York Academy of Sciences, 1462(1), 14-26. https://doi.org/10.1111/nyas.14235

Cable, J, Srikantiah, P, Crowe, JE, Pulendran, B, Hill, A, Ginsberg, A, Koff, W, Mathew, A, Ng, T, Jansen, K, Glenn, G, Permar, S, Wilson, I, Weiner, DB, Weissman, D & Rappuoli, R 2020, 'Vaccine innovations for emerging infectious diseases—a symposium report', Annals of the New York Academy of Sciences, vol. 1462, no. 1, pp. 14-26. https://doi.org/10.1111/nyas.14235

@article{1ad5161cd57440ccad9b39f43ed05502,

title = "Vaccine innovations for emerging infectious diseases—a symposium report",

abstract = "Vaccines have been incredibly successful at stemming the morbidity and mortality of infectious diseases worldwide. However, there are still no effective vaccines for many serious and potentially preventable infectious diseases. Advances in vaccine technology, including new delivery methods and adjuvants, as well as progress in systems biology and an increased understanding of the human immune system, hold the potential to address these issues. In addition, maternal immunization has opened an avenue to address infectious diseases in neonates and very young infants. This report summarizes the presentations from a 1-day symposium at the New York Academy of Sciences entitled “Innovative Vaccines against Resistant Infectious Diseases and Emerging Threats,” held on May 20, 2019.",

keywords = "CMV, DNA vaccine, Ebola, HIV, MERS, RNA vaccine, RSV, Zika, antimicrobial resistance, infectious disease, influenza, malaria, maternal immunization, monoclonal antibodies, systems vaccinology, tuberculosis, vaccine, vaccinology",

author = "Jennifer Cable and Padmini Srikantiah and Crowe, {James E.} and Bali Pulendran and Adrian Hill and Ann Ginsberg and Wayne Koff and Anuja Mathew and Tony Ng and Kathrin Jansen and Gregory Glenn and Sallie Permar and Ian Wilson and Weiner, {David B.} and Drew Weissman and Rino Rappuoli",

note = "Publisher Copyright: {\textcopyright} 2019 New York Academy of Sciences.",

year = "2020",

doi = "10.1111/nyas.14235",

language = "English (US)",

volume = "1462",

pages = "14--26",

journal = "Annals of the New York Academy of Sciences",

issn = "0077-8923",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Vaccine innovations for emerging infectious diseases—a symposium report

AU - Cable, Jennifer

AU - Srikantiah, Padmini

AU - Crowe, James E.

AU - Pulendran, Bali

AU - Hill, Adrian

AU - Ginsberg, Ann

AU - Koff, Wayne

AU - Mathew, Anuja

AU - Ng, Tony

AU - Jansen, Kathrin

AU - Glenn, Gregory

AU - Permar, Sallie

AU - Wilson, Ian

AU - Weiner, David B.

AU - Weissman, Drew

AU - Rappuoli, Rino

PY - 2020

Y1 - 2020

N2 - Vaccines have been incredibly successful at stemming the morbidity and mortality of infectious diseases worldwide. However, there are still no effective vaccines for many serious and potentially preventable infectious diseases. Advances in vaccine technology, including new delivery methods and adjuvants, as well as progress in systems biology and an increased understanding of the human immune system, hold the potential to address these issues. In addition, maternal immunization has opened an avenue to address infectious diseases in neonates and very young infants. This report summarizes the presentations from a 1-day symposium at the New York Academy of Sciences entitled “Innovative Vaccines against Resistant Infectious Diseases and Emerging Threats,” held on May 20, 2019.

AB - Vaccines have been incredibly successful at stemming the morbidity and mortality of infectious diseases worldwide. However, there are still no effective vaccines for many serious and potentially preventable infectious diseases. Advances in vaccine technology, including new delivery methods and adjuvants, as well as progress in systems biology and an increased understanding of the human immune system, hold the potential to address these issues. In addition, maternal immunization has opened an avenue to address infectious diseases in neonates and very young infants. This report summarizes the presentations from a 1-day symposium at the New York Academy of Sciences entitled “Innovative Vaccines against Resistant Infectious Diseases and Emerging Threats,” held on May 20, 2019.

KW - CMV

KW - DNA vaccine

KW - Ebola

KW - HIV

KW - MERS

KW - RNA vaccine

KW - RSV

KW - Zika

KW - antimicrobial resistance

KW - infectious disease

KW - influenza

KW - malaria

KW - maternal immunization

KW - monoclonal antibodies

KW - systems vaccinology

KW - tuberculosis

KW - vaccine

KW - vaccinology

UR - http://www.scopus.com/inward/record.url?scp=85081142269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081142269&partnerID=8YFLogxK

U2 - 10.1111/nyas.14235

DO - 10.1111/nyas.14235

M3 - Comment/debate

C2 - 31659752

AN - SCOPUS:85081142269

SN - 0077-8923

VL - 1462

SP - 14

EP - 26

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

IS - 1

ER -

Vaccine innovations for emerging infectious diseases—a symposium report

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this